FeesSafety
Pluang+

Wyndham Hotels boosts share buyback authorization by $400M, signaling confidence in cash flow and shareholder returns.

Company Fundamentals
29 Sep 2026, 13:30 WIB
PRNewsWire
View Source
Bullish
Wyndham Hotels boosts share buyback authorization by $400M, signaling confidence in cash flow and shareholder returns.

Wyndham Hotels & Resorts announced its Board of Directors has approved an increase of $400 million to its share repurchase authorization. This move reflects the Board's confidence in the company's strong business model and ability to generate significant cash flow. The repurchase program has no set end date and may be executed through various methods depending on market conditions. This decision underscores Wyndham's commitment to returning value to shareholders amid ongoing economic uncertainties.

Wyndham Hotels & Resorts' board increased its share repurchase authorization by $400 million. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Sep 29, 2026 17:11 WIB: out of 112 priced US stocks, 44 rose and 56 fell. Notable movers include CarMax, Inc (KMX) up 3.09% at USD 58.30 and Kohl's Corporation (KSS) down 2.94% at USD 17.65.

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
1 hour ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
1 hour ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
1 hour ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
3 hours ago
Cancore raises $7.2M seed round to expand cross-blockchain trading and automation tools.

Cancore raises $7.2M seed round to expand cross-blockchain trading and automation tools.

Cancore, a trading platform on Canton, secured $7.2 million in seed funding from investors including Paper Ventures and ArkStream Capital. The company aims to connect Canton-based assets with buyers and sellers on other blockchains, easing cross-netw...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App